Results 111 to 120 of about 12,036 (197)

Familial neurodegenerative disease with parkinsonism syndrome and amyotrophic lateral sclerosis

open access: yesНеврология, нейропсихиатрия, психосоматика, 2018
The concurrence of amyotrophic lateral sclerosis (ALS) with parkinsonism syndrome and dementia is described as Guam ALS, in which up to 70% of patients have a positive family history.
T. K. Davydova   +5 more
doaj   +1 more source

18F-AV-1451 positron emission tomography in Alzheimer's disease and progressive supranuclear palsy. [PDF]

open access: yes, 2016
The ability to assess the distribution and extent of tau pathology in Alzheimer's disease and progressive supranuclear palsy in vivo would help to develop biomarkers for these tauopathies and clinical trials of disease-modifying therapies.
Aigbirhio, Franklin I   +17 more
core   +1 more source

Clinical utility of FDG PET in Parkinson's disease and atypical parkinsonism associated with dementia [PDF]

open access: yes, 2018
PURPOSE: There are no comprehensive guidelines for the use of FDG PET in the following three clinical scenarios: (1) diagnostic work-up of patients with idiopathic Parkinson's disease (PD) at risk of future cognitive decline, (2) discriminating ...
Agosta, F   +13 more
core   +1 more source

Reply to “Neurophysiological Testing to Diagnose Stiff‐Person Spectrum Disorder”

open access: yes
Movement Disorders Clinical Practice, Volume 13, Issue 1, Page 303-304, January 2026.
João Moura   +5 more
wiley   +1 more source

Japanese longitudinal biomarker study in progressive supranuclear palsy and corticobasal degeneration: Clinical features of the first registered patients and short-term follow-up analysis

open access: yesClinical Parkinsonism & Related Disorders
Introduction: Progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD) manifest with variable clinical features. We initiated a multicenter prospective registry study—the Japanese Longitudinal Biomarker Study in PSP and CBD—in November ...
Hiroshi Takigawa   +14 more
doaj   +1 more source

Neologistic jargon aphasia and agraphia in primary progressive aphasia [PDF]

open access: yes, 2009
The terms 'jargon aphasia' and 'jargon agraphia' describe the production of incomprehensible language containing frequent phonological, semantic or neologistic errors in speech and writing, respectively.
Rohrer, JD, Rossor, MN, Warren, JD
core  

Botulinum toxin for the treatment of dystonia and pain in corticobasal syndrome

open access: yesBrain and Behavior, 2019
Background Dystonia is a key symptom in corticobasal syndrome (CBS), and upper limb dystonia is the most common phenotype. Dystonia‐associated pain is frequently reported and can be disabling, with poor benefit from oral treatments.
Elisa Unti   +6 more
doaj   +1 more source

Case report: Behavioral variant FTD confounding a language variant FTD in a case of PSP-CBS

open access: yesFrontiers in Dementia
Frontotemporal dementia (FTD) occurs in two main clinical subtypes, which can transition into one another: the behavioral variant (bvFTD) and the language variant (primary progressive aphasia; PPA).
Alexandra V. Jürs   +9 more
doaj   +1 more source

Potential Role of Transferrin and Vascular Cell Adhesion Molecule 1 in Differential Diagnosis Among Patients with Tauopathic Atypical Parkinsonian Syndromes

open access: yesDiagnostics
Background/Objectives: Transferrin is a multi-task protein commonly known for binding iron; however, it is involved in multiple crucial processes, including antimicrobial activity, the growth of different cell types, differentiation, chemotaxis, the cell
Natalia Madetko-Alster   +4 more
doaj   +1 more source

Cerebrospinal fluid biomarker supported diagnosis of Creutzfeldt-Jakob disease and rapid dementias: a longitudinal multicentre study over 10 years [PDF]

open access: yes, 2017
To date, cerebrospinal fluid analysis, particularly protein 14-3-3 testing, presents an important approach in the identification of Creutzfeldt-Jakob disease cases.
Aguzzi, Adriano   +20 more
core  

Home - About - Disclaimer - Privacy